The estimated Net Worth of John James O'connor is at least $5.12 Million dollars as of 29 February 2024. Mr. connor owns over 1 units of Lemaitre Vascular Inc stock worth over $4,993,590 and over the last 16 years he sold LMAT stock worth over $0. In addition, he makes $128,000 as Independent Director at Lemaitre Vascular Inc.
Sign up
Mr. Connor LMAT stock SEC Form 4 insiders trading
John has made over 13 trades of the Lemaitre Vascular Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 1 units of LMAT stock worth $87 on 29 February 2024.
The largest trade he's ever made was exercising 20,000 units of Lemaitre Vascular Inc stock on 2 August 2013 worth over $68,400. On average, John trades about 2,111 units every 86 days since 2008. As of 29 February 2024 he still owns at least 57,563 units of Lemaitre Vascular Inc stock.
You can see the complete history of Mr. connor stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John O'Connor biography
John J. O'Connor serves as Independent Director of the Company. Prior to his retirement in December 2006, Mr. O’Connor was a partner at PricewaterhouseCoopers LLP, an independent public accounting firm, from 1982 to December 2006, most recently serving as Vice Chairman of Services from June 2002 to November 2006. Mr. O’Connor served as the leader of the U.S. audit practice at PricewaterhouseCoopers from September 2000 to June 2002, and served as the Managing Partner of the firm’s Boston office from 1995 to September 2000. He is a director of mTuitive, Inc., a developer of clinical data capture and synoptic reporting software for use by healthcare professionals, Segue Manufacturing Services, LLC, a manufacturing services company, Health Data Analytics, Inc., a healthcare analytics company and Abt Associates, a mission driven global leader in research and program implementation in the fields of health, social and economic policy and international development. Mr. O’Connor has also served as a director of Aspect Medical Systems, Inc., a publicly-traded brain monitoring device company that was acquired by Covidien plc. in November 2009, and Open Pages, Inc., a provider of enterprise governance, risk and compliance management solutions that was acquired by IBM in October 2010. Mr. O’Connor is a graduate of Suffolk University and has attended the Harvard Business School’s Leadership in Professional Service Firms program and the executive M.B.A. program at the Amos Tuck School at Dartmouth College. The Board has concluded that Mr. O’Connor should serve on our Board due to his extensive capabilities in public financial accounting, his financial expertise, his experience and knowledge of operational management and strategic planning, and his insight into the operational challenges of a public company finance department. In addition, this experience qualifies Mr. O’Connor as an “audit committee financial expert.”
What is the salary of John Connor?
As the Independent Director of Lemaitre Vascular Inc, the total compensation of John Connor at Lemaitre Vascular Inc is $128,000. There are 8 executives at Lemaitre Vascular Inc getting paid more, with George LeMaitre having the highest compensation of $1,397,740.
How old is John Connor?
John Connor is 72, he's been the Independent Director of Lemaitre Vascular Inc since 2008. There are 1 older and 29 younger executives at Lemaitre Vascular Inc. The oldest executive at Lemaitre Vascular Inc is Dr. George D. LeMaitre, 87, who is the Founder and Chairman of Scientific Advisory Board.
What's John Connor's mailing address?
John's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.
Insiders trading at Lemaitre Vascular Inc
Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over $169,251,022 worth of Lemaitre Vascular Inc stock and bought 22,755 units worth $292,783 . The most active insiders traders include George W Le Maitre, Guido J Neels, and David B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,488,890. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth $107,236.
What does Lemaitre Vascular Inc do?
lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.
What does Lemaitre Vascular Inc's logo look like?
Complete history of Mr. connor stock trades at Lemaitre Vascular Inc
Lemaitre Vascular Inc executives and stock owners
Lemaitre Vascular Inc executives and other stock owners filed with the SEC include:
-
George LeMaitre,
Chairman of the Board, Chief Executive Officer -
David Roberts,
President, Director -
Joseph Pellegrino,
Chief Financial Officer, Director -
George W. LeMaitre,
Chairman & CEO -
Trent Kamke,
Senior Vice President - Operations -
David B. Roberts,
Pres & Director -
Joseph P. Pellegrino Jr.,
CFO, Treasurer, Sec. & Director -
Trent G. Kamke,
Sr. VP of Operations -
John O'Connor,
Independent Director -
Lawrence Jasinski,
Independent Director -
John Roush,
Independent Director -
Bridget Ross,
Independent Director -
James Russell,
Director, Operations -
Helen Goulding,
Director, Sales - Northern Europe -
Ryan Connelly,
Vice President - Research & Development -
Xiang Zhang,
Vice President, Regulatory Affairs -
Jacob Petersen,
Vice President, Asia-Pac -
Jonathan Ngau,
Vice President - Information Technology -
Roli Kumar-Choudhury,
Vice President, Quality Affairs -
Kimberly Cieslak,
Vice President - Marketing -
Chance Kriesel,
Vice President - Sales, The Americas -
Giovannella Deiure,
Vice President, Sales – Southern Europe -
Stephane Maier,
Vice President, EMEA Operations -
Andrew Hodgkinson,
Senior Vice President - Clinical, Regulatory and Quality Affairs -
Laurie Churchill,
Senior Vice President, General Counsel -
Stephane Maier,
Sr. VP of EMEA Operations -
Andrew Hodgkinson,
Sr. VP of Clinical, Regulatory & Quality Affairs -
Daniel J. Mumford,
Director of HR -
Kimberly L. Cieslak,
VP of Marketing -
Laurie A. Churchill,
Sr. VP & Gen. Counsel -
Dr. George D. LeMaitre,
Founder and Chairman of Scientific Advisory Board -
Cornelia W Le Maitre,
V.P., Human Resources,Director -
Michael T Wijas,
VP of Sales, The Americas -
Michael H Thomas,
Director -
Russell D Hays,
Director -
Aaron M Grossman,
General Counsel -
William N Jr Thorndike,
Director -
Equity Investors Lp/Ma Hous...,
-
George D Le Maitre,
Director -
Michael C Jackson,
Director -
Robert V Linden,
VP, North American Sales -
Peter R Gebauer,
President, International OP -
Kevin D Kelly,
V. P. North American Sales -
Maik D Helmers,
V.P. Central European Sales -
Guido J Neels,
Director -
David N Gill,
Director -
Duane M De Sisto,
Director -
Martha Shadan,
Director